President Donald Ramotar yesterday stressed that the naming of the New GPC as the sole pre-qualifier to supply drugs to the health sector was based on criteria-reaching principle, but aggrieved companies should appeal.
“This is purely a technical thing… They had an evaluation team… This was not done at Cabinet this was done at the Tender Board,” Ramotar said yesterday at a press conference.
The President was responding to questions on government’s recent announcement that only New GPC was pre-qualified to supply drugs to the health sector.
Head of the Presidential Secretariat Dr Roger Luncheon had said that the decision was based on the fact that the company outscored competitors in safety requirements and local investment.
Ramotar yesterday echoed what his Cabinet Secretary had stated but explained that companies
